U.S., March 4 -- ClinicalTrials.gov registry received information related to the study (NCT07446439) titled 'A Study to Evaluate Tradipitant on Treating Nausea and Vomiting Induced by GLP-1R Agonist Use' on Feb. 10.
Brief Summary: The goal of this study is to measure the effects of using Tradipitant to treat nausea and vomiting induced by GLP-1R agonist use in adults with class I or class II obesity, or adults who are overweight with at least one weight-related condition. The study is placebo-controlled with two treatment arms.
Study Start Date: Feb. 25
Study Type: INTERVENTIONAL
Condition:
Nausea and Vomiting
Obesity
Intervention:
DRUG: Tradipitant
Oral Capsule
DRUG: Placebo
Oral Capsule
Recruitment Status: NOT_YET_RECRUITING
S...